Remedium Lifecare Ltd

Remedium Life Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Remedium Lifecare Ltd

₹ 80.5 2.80%
03 Jul 10:59 a.m.
remlife.com BSE: 539561
About

Incorporated in 1988, Remedium Lifecare Ltd is in the business of trading in Advanced Pharmaceutical Intermediates and other pharma products

Key Points

Business Overview:[1]
Company does trading and sale of API intermediates (KSMs & CRMs) and various other raw materials used in API trading to innovator and generic pharmaceutical players in Domestic and International markets

Website BSE
  • Market Cap ₹ 811 Cr.
  • Current Price ₹ 80.5
  • High / Low ₹ 180 / 58.5
  • Stock P/E 24.8
  • Book Value ₹ 4.26
  • Dividend Yield 0.00 %
  • ROCE 99.5 %
  • ROE 123 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has delivered good profit growth of 405% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 101%

Cons

  • Stock is trading at 18.4 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 1.11%
  • Earnings include an other income of Rs.21.1 Cr.
  • Promoter holding has decreased over last 3 years: -33.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
56 138 120 206 40 99 158 176 76 330 469 1,834 1,408
55 138 119 205 41 93 156 175 78 323 462 1,779 1,444
Operating Profit 0 0 1 1 -1 7 2 2 -3 7 6 55 -35
OPM % 1% 0% 1% 0% -1% 7% 1% 1% -4% 2% 1% 3% -2%
0 0 0 0 0 0 0 0 0 0 4 14 3
Interest 0 0 0 0 0 0 0 0 -0 0 0 0 4
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 1 1 -1 6 2 2 -3 7 10 69 -36
Tax % 38% 0% 0% 0% -62% 0% 0% 0% -70% 28% 37% 0% -49%
0 0 1 1 -1 6 2 2 -5 5 7 69 -54
EPS in Rs 0.03 0.04 0.11 0.07 -0.12 0.64 0.22 0.15 -0.47 0.52 0.65 6.82 -5.33
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 1 2 4 1 0 0 3 90 505 510 4,040
1 1 2 4 1 0 0 2 89 503 502 4,006
Operating Profit 0 0 -0 -0 -0 0 -0 0 1 2 8 34
OPM % 7% 3% -8% -8% -7% 0% -44% 14% 1% 0% 2% 1%
0 0 1 0 0 0 0 0 0 0 0 21
Interest 0 0 0 0 0 0 0 0 0 0 0 5
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 1 0 0 0 0 0 1 2 7 50
Tax % 0% 50% 21% 0% 0% 0% 100% 24% 26% 29% 27% 35%
0 0 1 0 0 0 0 0 0 1 5 33
EPS in Rs 0.00 0.00 0.06 0.00 0.00 0.00 0.00 0.03 0.05 0.11 0.54 3.25
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 659%
3 Years: 255%
TTM: 692%
Compounded Profit Growth
10 Years: %
5 Years: 405%
3 Years: 309%
TTM: 503%
Stock Price CAGR
10 Years: %
5 Years: 154%
3 Years: 177%
1 Year: -46%
Return on Equity
10 Years: %
5 Years: 88%
3 Years: 101%
Last Year: 123%

Balance Sheet

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 4 4 4 4 4 4 4 4 4 4 4 10
Reserves -0 -0 -1 -1 -1 -1 -1 -0 0 1 7 33
1 1 0 0 0 0 0 0 10 0 0 58
2 1 3 2 0 0 0 1 24 219 1,144 1,847
Total Liabilities 6 6 6 5 3 3 4 4 39 224 1,154 1,948
2 2 1 0 0 0 0 0 0 0 0 0
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
4 4 4 5 3 3 4 4 38 224 1,154 1,948
Total Assets 6 6 6 5 3 3 4 4 39 224 1,154 1,948

Cash Flows

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 -1 0 -0 -0 -0 -10 11 20 -74
0 1 0 0 1 -0 -0 -0 -0 0
-0 -0 0 0 0 0 10 -11 -0 54
Net Cash Flow -0 0 0 -0 1 -0 -0 1 20 -20

Ratios

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 203 120 341 265 596 2,117 319 189 96 46 123 83
Inventory Days 1,506 1,129 243 78 0 0 5 12
Days Payable 162 102 438 129 62 65
Cash Conversion Cycle 1,547 1,147 146 214 596 2,117 319 189 96 46 67 30
Working Capital Days 607 566 107 200 524 2,159 4,745 323 54 2 -8 9
ROCE % 1% 1% 0% 1% 1% 11% 7% 18% 103% 100%

Shareholding Pattern

Numbers in percentages

6 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
8.43% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.08% 0.04% 0.04%
91.57% 98.89% 98.89% 98.89% 98.89% 98.88% 98.88% 98.88% 98.84% 98.81% 98.86% 98.85%
No. of Shareholders 8458407146596226046227051,7303,9883,85915,587

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports